NNP
ACHV icon

Nachman Norwood & Parrott’s Achieve Life Sciences ACHV Stock Holding History

Nachman Norwood & Parrott’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-75
Closed -$1K – 275
2020
Q3 		$1K Buy
+75
New +$688 ﹤0.01% 1131

Other funds holding ACHV

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HR
Hayden Royal Charlotte, North Carolina $42.7M AUM 33.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Nachman Norwood & Parrott's ACHV Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Achieve Life Sciences (ACHV) in Q4 2020, closing a stake of 75 shares — an estimated $1K sold.

Nachman Norwood & Parrott first reported a position in ACHV in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 16 funds tracked by Wall St. Rank hold ACHV as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Achieve Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 75 Achieve Life Sciences shares in Q4 2020, an estimated $1K.
  • Nachman Norwood & Parrott first reported a position in Achieve Life Sciences in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Achieve Life Sciences position peaked at $1K in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.